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POTENTIAL ADULTERATING CAPABILITIES OF COMMERCIAL ZINC 
PRODUCTS ON PRELIMINARY IMMUNOASSAY SCREENINGS FOR THE 
DETECTION OF ETHYL GLUCURONIDE (ETG) 
 
DANIEL ARTHUR LEDOUX 
 
ABSTRACT 
 Alcohol has been consumed over many centuries, but its connection to criminal 
activity and accidental fatalities has become a prominent concern in more recent 
centuries(1).  Scientists have developed numerous testing methods to detect alcohol 
consumption.  Numerous studies have recently suggested that zinc has the potential to 
interfere with the results of these testing methods for drugs of abuse such as enzyme-
linked immunosorbent assay (ELISA) and enzyme multiplied immunoassay technique 
(EMIT) (2, 3).  False negatives have been reported from urine testing of drugs such as 
cocaine, methamphetamine, opiates, and cannabinoids.  Nevertheless, minimal research 
has been conducted concerning zinc’s effect on the adulteration of alcohol metabolite 
testing.  Ethyl glucuronide (EtG) is a promising ethanol metabolite for the confirmation 
of alcohol consumption.  Previous research conducted by Shanna Cawley, a graduate 
from the Boston University School of Medicine’s Biomedical Forensic Sciences 
program, has found that zinc sulfate is ineffective at producing conclusive false negative 
results using two immunochromatographic assay brands in synthetic urine solutions(4).   
 vi 
This study uses five different immunoassay brands, five different zinc sources, 
and two distinct matrices to determine the effectiveness of commercial zinc products as 
adulterants in drugs of abuse testing.  Zinc and EtG solutions were produced at 
concentrations of 15mg/mL and 750ng/mL, respectively.  A positive control, negative 
control, and two to three experimental trials were conducted for each immunoassay brand 
and each zinc source resulting in a total of 165 tests.  Approximately sixty experimental 
trials in synthetic urine were invalidated or positive for the presence of EtG (81%) in zinc 
adulterated EtG solutions.  Immunoassay kits produced false positive results when testing 
human urine from subjects who abstained from alcohol consumption  Therefore, 
preliminary immunoassay screenings for the presence of EtG are not a reliable method 
for confirming alcohol consumption.  Previously researched methods, ELISA and EMIT, 
and confirmatory methods such as gas chromatography-mass spectrometry (GC-MS) and 
liquid chromatography-mass spectrometry (LC-MS) are currently the most robust and 
reliable techniques for EtG detection in urine. 
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1. INTRODUCTION 
1.1 Alcohol, Crime and Mortality 
 For millennia humans have consumed alcohol produced by the fermentation of 
available sugar sources (i.e. fruits and vegetables)(1).  Only in recent centuries has 
alcohol consumption become an issue of legal scrutiny, especially concerning its 
involvement in criminal acts and fatal injuries.  Recent studies indicate that more than 
139 million people (approximately 43% of the U.S. population) consumed alcohol in 
2014(6). Alcohol consumption alone is not considered a criminal act (when imbibed 
above the legal age) and a majority of people consuming alcohol do not commit crimes.  
However, there are a considerable number of criminal acts committed while under the 
influence of alcohol.  The Bureau of Justice Statistics (BJS) compiled data concerning 
alcohol and its relation to crime from 2002 to 2008.  A survey conducted in 2004, 
Survey of Inmates in State and Federal Correctional Facilities, indicated that 32.6% 
(±0.70%) of state inmates and 18.5% (±1.15%) of federal inmates had consumed 
alcohol at the time of their offense(7).  In addition, the National Highway Traffic Safety 
Administration (NHTSA) reports that alcohol was involved in 9,967 traffic fatalities in 
2014(8).  These statistics underline the necessary use of screening techniques to quickly 
and accurately detect alcohol and its metabolites.  
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1.2 Ethanol and its Metabolism 
 
Figure 1. The chemical structure of ethanol  
(Produced using ChemBioDraw Ultra 14.0) 
 
 Ethanol (EtOH), depicted in Figure 1, is a naturally occurring organic compound 
formed through the process of anaerobic respiration used by a variety of organisms to 
metabolize carbohydrates.  It is the narcotic component in potable alcohol.  When a 
person consumes alcohol there are a multitude of external and internal effects based on 
the level of intoxication and the concentration of alcohol in a person’s blood, otherwise 
known as the blood alcohol concentration (BAC). The range of blood alcohol 
concentrations and the subsequent effects of each are positively correlated.  For 
example, a person casually drinking beer (~5% EtOH), wine (~7-20% EtOH), or liquor 
(~40% EtOH) can become mildly impaired.  Heavier drinking can lead to increased 
impairment, severe impairment, and, eventually, life threatening impairment(9).  
Regardless of the degree to which a person consumes ethanol, this molecule is 
processed within the body through a variety of metabolic pathways or excreted before 
metabolism can occur. 
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1.2.1 Oxidative Metabolic Pathways and Products 
 The major metabolic pathways by which approximately 95% of ethanol is 
transformed into numerous products are through oxidative methods.  Oxidation 
occurs as ethanol loses electrons and a second molecule, nicotinamide (NAD+ → 
NADH) gains electrons.  The most common oxidative reaction transforms ethanol 
into acetaldehyde using alcohol dehydrogenase (ADH), cytochrome P450 2E1 
(CYP2E1), or catalase(10, 11).  Eventually, acetaldehyde is converted into acetic acid 
using aldehyde dehydrogenase 2 (ALDH2).  Figures 2 and 3 depict the structure of 
the two products of this pathway.  Figure 4 shows the reaction by which alcohol 
undergoes oxidative metabolism using ADH and ALDH2. 
  
Figure 2. The chemical structure of acetaldehyde 
  (Produced using ChemBioDraw Ultra 14.0) 
  
Figure 3. The chemical structure of acetic acid 
(Produced using ChemBioDraw Ultra 14.0) 
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Figure 4. Oxidative metabolism of EtOH using ADH and ALDH2 
(Produced using ChemBioDraw Ultra 14.0) 
 
Following oxidative metabolism, acetic acid will then become acetyl-CoA and enter 
the Krebs cycle or be directly broken down into carbon dioxide (CO2) and water 
(H2O) (11).   
 
1.2.2 Non-oxidative Metabolic Pathways and Products 
 Non-oxidative metabolism comprises approximately 5% of ethanol 
biotransformation.  Three different pathways have been characterized including the 
formation of fatty acid ethyl esters (FAEE), phosphatidylethanol (PEth), and ethyl 
glucuronide (EtG)(12).  Fatty acid ethyl esters are the largest group of products 
formed from non-oxidative metabolism followed by PEth and EtG, respectively. 
 In the 1980s and 1990s, research concerning FAEEs determined the pathway by 
which they were formed.  Mogelson, Pieper, and Lange conducted thermodynamic 
and kinetic experiments to examine the energy and time it takes to form these non-
oxidative metabolites(13).  They combined a series of solutions containing various 
concentrations of ethanol and oleic acid to form ethyl oleate, a short-chain FAEE.  
Then, they attempted to aggregate the ethyl oleate and quantify the isolated product 
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using gas chromatography.  Without the presence of any enzyme, the amount of ethyl 
oleate was negligible and could not be quantified above negative control trials(13). 
However, when the isolated catalyst, fatty acid ethyl ester synthase, was introduced 
the rate was quantifiable and a maximal rate was observed at a neutral pH and with 
physiological concentrations of ethanol and oleic acid(13).  Lastly, they calculated the 
Gibbs free energy of each reaction, uncatalyzed and catalyzed, and found their values 
to be 32.5kcal/mol and 19.9kcal/mol, respectively.  This study demonstrates how  
small amounts of metabolites undergo nonoxidative metabolism.  Without a catalyst 
this process would be slow and produce trace concentrations. 
 
1.2.2.1 Ethyl glucuronide (EtG) 
 
Figure 5. The chemical structure of ethyl glucuronide 
(Produced using ChemBioDraw Ultra 14.0) 
 
Forensic research involving a resilient and detectable biomarker, ethyl 
glucuronide (Figure 5), has been conducted over the past two decades(14-19).  EtG 
 6 
was discovered in 1901 and detected in rat and human urines over seventy years 
later(20, 21).  Although, EtG was discovered over a century ago, its biochemical 
synthesis involves a pathway only recently characterized by Foti and Fisher in 
2005(22).  This biochemical transformation employs a family of proteins known as 
Uridine-5’-diphospho-glucuronosyltransferases (UGTs) to catalyze the 
glucuronidation of ethanol and glucuronic acid into ethyl glucuronide (Figure 
6)(22). 
 
Figure 6. Biochemical reaction of EtOH and glucuronic acid to form EtG 
(Produced using ChemBioDraw Ultra 14.0) 
 
1.2.3 The Prevalence of Alcohol in Foods and Nonalcoholic Beverages 
 Despite a person’s efforts to abstain from alcohol consumption, ethanol is 
prevalent in a wide assortment of foods, beverages, medications and household 
products.  The potential for incidental exposure to ethanol is extremely high as 
conveyed by various studies since the mid-90s(23-25).  Goldberger and his associates 
tested for ethanol in carbonated beverages(23).  Their research revealed that some 
contain as much as 0.221% w/v ethanol and some noncarbonated beverages, such as 
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Tropicana Fruit Punch, had a mean ethanol concentration as high as 0.096% w/v(23).  
Researchers have hypothesized that particular flavoring agents are stored as a 
solubilized component in ethanol and they attribute the addition of such agents to 
drinks as the most likely cause.   
 Moreover, food products have been tested for ethanol content.  A study conducted 
in 1998 indicated that a variety of edible goods contained a detectable concentration 
of ethanol(24).  An unspecified number of subjects were asked to imbibe, ingest, or 
retain in their mouths a variety of beverages and foods.  A DataMaster breathalyzer 
test was used to detect the concentration of ethanol during and after consumption of 
these samples.  Products such as Domino’s Pizza Crust and Rosemary Onion Bread 
had ethanol concentrations of 0.088g and 0.098g ethanol per 100g food product, 
respectively(24).  Neither could produce a positive result unless large quantities were 
eaten.  However, any concentration over 0.1g ethanol per 100g food product 
produced  a positive result using the DataMaster breathalyzer test while the food was 
still retained in a subject’s mouth(24).  Both food and nonalcoholic beverages have 
the potential to produce altered breathalyzer results and consumption of such products 
could lead to the formation of EtG despite a person’s attempts to abstain from 
alcoholic products. 
 
1.2.4 The Prevalence of Alcohol in Consumer Products  
 Ingestion is only one method by which a person may be exposed to alcohol.  
Contact and inhalation are two other means.  Although, they are not often taken into 
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consideration when a person abstains from alcohol for legal or personal reasons.  
Regardless, a person may find himself or herself unknowingly introducing this 
substance into their bodies when using common consumer products.  Deodorants, 
insect repellants, cleaning agents, and odor neutralizers are only a few among 
approximately 1,600 ethanol-containing products within the U.S. Department of 
Health and Human Services Household Product Database(25).  Ubiquitous brands 
such as Right Guard®, Off!®, Clorox®, and Febreze™ are frequently observed 
throughout the list which may indicate the extreme difficulty which a person may 
have when avoiding contact with alcohol throughout daily life. 
 
1.3 Preliminary Immunoassay Methodologies 
 Over the past decade immunological tests have become more common preliminary 
testing methods in preference over chemical testing methods due to the related cost of 
each.  A variety of antigen specific and molecule specific antibodies have been used to 
detect the presence of biological matrices such as blood, saliva, semen, and urine.  The 
National Research Council (NRC) reports that specific tests to detect human blood and 
seminal proteins are promising improvements in the forensic science field(26).  A 
particular screening method employed by forensic scientists to detect drug components 
within urine and other biological matrices are enzyme immunoassays (EIA) such as 
enzyme-linked immunosorbent assays (ELISA) and immunochromatographic assays. 
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1.3.1 Enzyme-Linked Immunosorbent Assay (ELISA) 
 Enzyme-linked immunosorbent assays (ELISA) tests involve multiple antibodies 
complexing with a specific antigen(27).  A standard ELISA test incorporates fixed 
monoclonal antibodies (Ab) that bind to antigen (Ag) molecules when washed with 
an antigen solution.  Upon binding of the antigen, a second, different set of antibodies 
binds to the antigen and produces an antibody-antigen-antibody sandwich.  The 
sandwich becomes detectable with fluorescent or colorimetric enzyme-labeled 
antiglobulins(27).  The entire complex can then be analyzed qualitatively as well as 
quantitatively.  Other assay methods involve direct or indirect binding of the antigen 
to the antibody or vice versa(27).  Figure 7 shows the antibody-antigen-antibody 
sandwich. 
 
 
 
 
 
 
 
 
 
 
Figure 7. The antibody-antigen-antibody sandwich 
 
 1.3.2 Screening Immunoassaysssays 
 Numerous types and brands of enzyme assays have emerged into the forensic 
field.  One type of immunochromatographic testing involves liquid testing medium 
  
  
Ag  
Ab  
Ab 
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and another involves a solid testing medium  Liquid-based methods such as the 
Thermo Scientific™ DRI® ethyl glucuronide enzyme immunoassay have been 
widely studied and validated(28-30).  Thermo Scientific’s product generates both 
qualitative and semi-quantitative results.  Its mechanism of action involves an enzyme 
that reduces NAD+ into NADH.  The activity of the enzyme is altered by competitive 
binding between glucose-6-phosphate dehydrogenase (G6PDH)-labeled EtG and free 
EtG within the sample.  This change in enzyme activity allows for accurate detection 
of EtG at concentrations greater than 500ng/mL using the signal strength of the active 
enzyme at 340 nanometers (nm).  In addition, semi-quantitation can occur if the 
levels of EtG are between 100ng/mL and 2000ng/mL as reported by the 
manufacturer(28). 
Immunoassay dip cards and test panels operate by competitive binding that 
produces a colorimetric result.  The control region (C) has fixed goat antibodies 
specific to Immunoglobulin G (IgG) mouse antibodies.  The test region (T) of the 
strip contains immobilized duck egg protein conjugates specific to IgG.  Mouse 
antibodies coating the sample end of the strip specifically interact with EtG.  As the 
test strip absorbs the biological fluid in question, the mouse antibodies move across 
the strip.  If EtG is absent from the solution, then IgG binds to both the mouse 
specific antibodies in the T and C regions generating a visible color.  If EtG is present 
at a sufficient concentration (usually 500ng/mL), then it binds to the mouse IgG 
antibodies and prevents the duck egg protein from conjugating with the IgG 
antibodies. Therefore, when IgG mouse antibodies do not bind to the T region, no 
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visible color is produced.  EtG inhibits the expression of the color-producing 
molecule attached to the T and C region antibodies.  Figure 8 depicts the various 
scenarios by which an immunoassay panel indicates the presence or absence of EtG. 
A positive result indicates the presence of EtG.  An invalid result indicates that the 
test did not function properly.  Finally, a negative result suggests that no EtG is 
present. 
 
 
 
 
 
 
  
Positive           Invalid         Negative 
Figure 8. Immunoassay Panel Results 
 
1.3.3 EtG Testing Limitations  
 The usefulness of immunochromatographic assays is that they are inexpensive, they 
are easy-to-use, and they rapidly produce results.  A review of literature over the past 
fifty years indicates that EtG is stable for up to five weeks when refrigerated(19).  The 
compound has a reported limit of detection with cut-off values as low as 100-200µg/L 
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and a detection window up to 130 hours in some studies(19).   Nevertheless, the presence 
of EtG only indicates that a person has been exposed to ethanol, but testing does not 
indicate the source.  Therefore, false positives and false negatives are possible by a 
variety of means including bacterial interference and alternative ethanol exposure.  In 
particular, EtG testing is used to detect ethanol consumption, but research into high 
alcohol content mouthwash and hand sanitizer has indicated some challenges to this 
screening method.  Two studies conducted by Reisfeld et al. in 2011 tested the potential 
effect of high ethanol content mouthwash and hand sanitizer on EtOH, EtG, and ethyl 
sulfate (EtS) screening tests(31).  The first paper included ten subjects between the ages 
of 18 and 70(31).  All subjects abstained from ethanol contact for five days prior to 
experimentation.  Over the course of the first three days each participant was asked to 
gargle a 20mL volume of Listerine for thirty seconds after every meal.  On the fourth 
day, urine samples were collected at intervals 2, 4, and 6 hours after the final exposure on 
the morning of Day 4.  This study concluded that subjects who regularly used high 
ethanol content mouthwash could produce a false positive result on urinary EtG 
immunoassay screenings if the limit of detection (LOD) was set at 100ng/mL to 
200ng/mL as confirmed by LC-MS-MS(31).  Reisfeld recommended an LOD at 
500ng/mL or greater to distinguish between incidental exposure and intentional alcohol 
consumption.  Furthermore, a second study explored the potential interference of hand 
sanitizer on the same screening method(32).  Reisfeld and his colleagues studied eleven 
subjects who were asked to avoid all contact with ethanol for five days prior to the 
beginning of the study.  During the first three days each subject was required to rub 
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Purell hand sanitizer on his or her hands every 5 minutes for a total of 10 hours.  Urine 
specimens were collected prior to and following this period every day.  One final urine 
sample was collected on Day 4.  This study determined that moderate to intensive use of 
hand sanitizer could generate an EtG concentration as high as 2001ng/mL with a majority 
of subjects producing EtG concentrations above the 500ng/mL cut-off.  This research 
suggests that incidental exposure to EtOH can generate a positive reading on preliminary 
screening tests.  Nevertheless, there is no measurable way to determine the source of 
ethanol or the intention of the person tested. 
A follow-up study conducted by Gessner et al. in recent months disagrees with 
Reisfeld (33).  Thirty-three volunteers were involved in two distinct testing phases.  The 
first test phase involved abstaining from common forms of ethanol for 48 hours prior to 
and 24 hours following an 8-hour testing period.  During this testing period subjects were 
asked to repeatedly use an ethanol-based sanitizer on their hands.  The second phase 
allowed volunteers to consume alcohol and use alcohol-containing products as usual.  
After two days, the subjects performed the same actions as described in the first phase 
testing period.  The mean concentrations for EtOH and EtG were found to be 1.7mg/L 
and 281.4 ng/mL respectively during the first phase.  Mean concentrations were 
approximately 61 times greater when subjects were allowed to use ethanol-based 
products and consume alcoholic beverages.  Gessner argues that the concentrations of 
EtOH and EtG produced by contact with a hand sanitizer are too small to be considered 
relevant when compared to other methods of introducing alcohol to the body(33) 
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 Lastly, Statchel and Skopp recently documented the effect of various compounds and 
enzymes on the formation and inhibition of EtG and EtS(34).  In particular, they 
examined the potential role of quercetin, kaempferol, and resveratrol on the formation of 
these two compounds.  Ethanol, enzymes, and the three inhibitory compounds in question 
were incubated to determine the percent reduction of ethanol conjugation.  The suspected 
inhibitors were added in three different concentrations to determine their effect on a 
number of UGT variants.  Statchel and Skopp concluded that quercetin, kaempferol, and 
resveratrol were inhibitors of EtG and EtS formation.  However, resveratrol was deemed 
only a competitive inhibitor with negligible to moderate effects on both metabolites.  The 
study showed that variable rates of EtG and EtS documented between individuals could 
be partially explained by the presence of these inhibitors commonly found in a variety of 
edible products(34). 
 
1.4 Confirmatory Testing Methodologies 
 Two recent papers discuss the recommendations given by many researchers that EtG 
preliminary testing should be followed up by confirmatory testing such as various forms 
of chromatography and mass spectrometry(35, 36).  Albermann, Musshoff, and Madea 
validated an HPLC-MS method for forensic use in the detection of both EtG and EtS(35).  
They analyzed 87 urine samples for the presence of these two compounds.  Their method 
was able to detect and quantify EtG at concentrations as low as 5ng/mL and 19ng/mL, 
respectively.  In addition, EtS was detected and quantified at concentrations as low as 
4ng/mL and 15ng/mL, respectively(35).  These low LODs and LOQs have suggested that 
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chromatrography-mass spectrometry techniques continue to be the gold standard upon 
which further research has only improved.  Monosik and Dragsted followed up the 
Albermann team with an ultra high performance liquid chromatography-mass 
spectrometry/mass spectrometry (UHPLC-MS/MS) method to quantify EtG as well as 
numerous other direct and indirect alcohol biomarkers in 2016(36).      
 
1.5 Zinc: An Immunoassay Adulterant 
 Researchers have identified high concentrations of zinc in urine samples tested for the 
presence of drugs of abuse(2, 3).  The most commonly used form of zinc is zinc sulfate 
(Figure 9).  In addition, zinc gluconate (Figure 10) is present in a number of food 
supplements such as Nature’s Bounty and Nature Made zinc tablets(3).  Studies indicate 
that ingested zinc sulfate concentrations are ~4200 times lower than the effective 
adulterant concentrations(3, 37).  Regardless, zinc has been found to interfere with 
ELISA and EMIT testing methods(2, 3).   
 In 2011 Venkatratnam and his colleagues used urine from seven healthy volunteers 
along with methanol-based drug standards in ELISA testing for the following drugs of 
abuse: cocaine, methamphetamine, and tetrahydracannabinol (THC)(2).  Zinc sulfate was 
used to generate different concentrations of zinc in drug-free urine samples.  Three 
volunteers contributed drug-free urine samples to analyze the effect of variable pH 
produced by zinc contamination.  Finally, four volunteers contributed urine samples 
following consumption of THC and zinc gluconate tablets to determine if ingested zinc 
could adulterate the ELISA method.  The study indicates that zinc can interfere with and 
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produce a false negative when used for drug of abuse testing(2).  A further comment from 
researchers suggests that ingested zinc has greater adulterant qualities because it does not 
produce the turbidity observed in solutions generated in vitro.   
 A follow-up study conducted by Lin and Strathmann in 2013 produced similar results 
using the EMIT method(3).  Thirty-one volunteers, consisting of both males and females 
between the ages of 23 and 63, contributed urine samples prior to and following ingestion 
of self-administered 50mg zinc gluconate tablets.  Researchers asked subjects to collect a 
urine sample on the morning of Day 2 and then consume four zinc tablets on the evening 
of Day 2.  Subjects were then asked to consume another four zinc tablets on the morning 
of Day 3 and provide a post-ingestion urine sample the same morning. This study found 
that concentrations of zinc greater than 5mg/mL in the case of methamphetamine and 
greater than 10mg/mL for all other drugs tested produced a false negative EMIT result(3).  
Both studies highlight the prevalence of zinc’s effectiveness to adulterate liquid-based 
immunoassay methods.     
 A recent study by Welsh et al. reports on two spot tests developed to detect zinc 
sulfate in urine(38).  Researchers combined solutions of zinc sulfate with sodium 
hydroxide or a two-step process of sodium chromate and sodium hydroxide to form 
precipitates.  Introduction of sodium hydroxide yielded a white precipitate visible within 
solution.  The two-step method spot test generated a bright yellow precipitate.  Both spot 
tests were deemed effective at qualitatively detecting the presence of zinc sulfate at 
concentrations greater than 10mg/mL.  Zinc-adulterated urine samples containing drugs 
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of abuse and alcohol showed reduced detection or no detection of the drugs or alcohol 
when concentrations greater than 10mg/mL zinc sulfate were present. 
 
 
Figure 9. Chemical structure of zinc sulfate (ZnSO4) 
(Produced using ChemBioDraw Ultra 14.0) 
 
 
Figure 10. Chemical structure of zinc gluconate (ZnC12H22O14) 
(Produced using ChemBioDraw Ultra 14.0) 
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2. MATERIALS & METHODS 
2.1 Materials 
 Solutions of EtG and five different zinc sources were made in 50mL and 15mL 
Fisher Scientific Falcon™ Tubes (Pittsburgh, PA), respectively.  All immunoassay tests 
were performed in Sigma-Aldrich 1.5mL Eppendorf LoBind microcentrifuge tubes (St. 
Louis, MO).  A Denver Instruments Pinnacle Balance (Bohemia, NY) was used to 
measure the desired masses of each zinc source. 
 SurineTM Negative Urine Control (1L) was purchased from Cerilliant (Round 
Rock, TX) and Drug Free Urine (Frozen) (835mL) was purchased from Utak (Valencia, 
CA).  Additional human urine samples were collected from anonymous donations to the 
Biomedical Forensic Sciences program.  Solid Ethyl-β-D-glucuronide (2x2mg) was 
purchased from Athena Enzyme Systems (Baltimore, MD).   
 Five commercially available zinc products were evaluated in this study.  Zinc 
sulfate heptahydrate (ZnSO4•7H2O) (500g) and zinc sulfate monohydrate 
(ZnSO4•1H2O) (250g) were purchased from Sigma-Aldrich (St. Louis, MO).  Zinc 
gluconate was purchased from NatureMade (Mission Hills, CA) and Nature’s Bounty 
(Bohemia, NY).  Zinc sulfate monohydrate was purchased as the product Zinc 
Challenge from Designs for Health (Suffield, CT).   
 Five different ethyl glucuronide immunoassay screening tests were evaluated as 
well.  PreScreen Plus Drug Test Dip Cards (2x25 cards) were ordered from Drug Tests 
in Bulk (West Hills, CA).  ETG Urine Alcohol Ethyl Glucuronide Test Dip Cards 
(2x25 tests) were ordered from TransMed Drug Testing and Laboratory Supplies 
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(Alfaretta, GA).  ETG Test Dip Card Urine tests (2x25 tests) were ordered from 
CLIAWaived Inc. (San Diego, CA). Ethyl Glucuronide Test Cassettes (2x40 cassettes) 
were ordered from SmarTox (Irving, TX). 
 
2.2 Experimental Design 
 This experiment used a multitude of zinc products and immunoassays tests.  The 
devised testing scheme involved each immunoassay brand being tested with adulterated 
solutions of each zinc product in either synthetic urine or human urine.  Five 
immunoassay cards were used for each round of testing including three trials, one 
positive control, and one negative control (Table A).   
Table A. Initial Scheme for Testing the Effects of Zinc on Various Matrices and 
Immunoassays 
Matrix Synthetic Urine (1) Human Urine (2) 
Zinc Source 
Sigma-
Aldrich 
ZnSO4•7H2O 
(1) 
Sigma-
Aldrich 
ZnSO4•1H2O 
(2) 
Nature’s 
Bounty Zinc 
Gluconate (3) 
NatureMade 
Zinc Gluconate 
(4) 
Zinc 
Challenge 
(5) 
Immunoassay 
PreScreen 
Plus (1) 
HETG-
105A (2) 
TransMed  
(3) 
CLIAWaived 
(4) 
SmarTox    
(5) 
Trial Name 
Positive 
Control 
Trial 1 Trial 2 Trial 3 
Negative 
Control (N) 
# of Tests 125 125 
 
 Each matrix was assigned a number 1 or 2.  Then, each zinc source was assigned 
a number 1, 2, 3, 4, and 5 respectively.  Finally, each immunoassay was assigned a 
number 1, 2, 3, 4, and 5 respectively.  Therefore, a test labeled 1.1.1 meant that the 
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matrix was Surine™, the zinc source was Sigma-Aldrich ZnSO4•7H2O, and the 
immunoassay brand was PreScreenPlus (Table B). 
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Table B. Numbering Scheme for the Contents of Each Microcentrifuge Tube 
 Matrix Zinc Source Immunoassay 
I.D. 1 2 1 2 3 4 5 1 2 3 4 5 
1.1.1 X  X     X     
1.1.2 X  X      X    
1.1.3 X  X       X   
1.1.4 X  X        X  
1.1.5 X  X         X 
1.2.1 X   X    X     
1.2.2 X   X     X    
1.2.3 X   X      X   
1.2.4 X   X       X  
1.2.5 X   X        X 
1.3.1 X    X   X     
1.3.2 X    X    X    
1.3.3 X    X     X   
1.3.4 X    X      X  
1.3.5 X    X       X 
1.4.1 X     X  X     
1.4.2 X     X   X    
1.4.3 X     X    X   
1.4.4 X     X     X  
1.4.5 X     X      X 
1.5.1 X      X X     
1.5.2 X      X  X    
1.5.3 X      X   X   
1.5.4 X      X    X  
1.5.5 X      X     X 
2.1.1  X X     X     
2.2.1  X  X    X     
2.3.1  X   X   X     
2.4.1  X    X  X     
2.5.1  X     X X     
2.1.3  X X       X   
2.2.3  X  X      X   
2.3.3  X   X     X   
2.4.3  X    X    X   
2.5.3  X     X   X   
 
 22 
      Preliminary testing of human urine as a matrix indicated that some immunoassay 
brands reported positive results when a negative urine control was applied.  Any brand 
reporting a positive result prior to the addition of EtG was excluded from further human 
urine testing.  Three of the five immunoassay kits were excluded including ETG Urine 
Alcohol Ethyl Glucuronide Test Dip Cards, ETG Test Dip Card Urine tests, and Ethyl 
Glucuronide Test Cassettes.  A revised testing scheme for human urine was devised 
based on the results of this preliminary testing and included PreScreenPlus and 
TransMed immunoassay kits (Table C). 
Table C. Revised Scheme for Testing the Effects of Zinc on Immunoassays Using 
Human Urine 
Matrix Human Urine (2) 
Zinc Source 
Sigma-Aldrich 
ZnSO4•7H2O 
(1) 
Sigma-Aldrich 
ZnSO4•1H2O 
(2) 
Nature’s 
Bounty Zinc 
Gluconate (3) 
NatureMade 
Zinc 
Gluconate (4) 
Zinc 
Challenge 
(5) 
Immunoassay PreScreen Plus (1) TransMed (3) 
Trial Name Positive Control Trial 1 Trial 2 
Negative 
Control 
# of Tests 40 
 
2.3 Method 
2.3.1 Surine™ Method 
 Ethyl glucuronide (2mg) was dissolved in Surine™ (2mL) to produce a 1mg/mL 
EtG solution.  This original solution was diluted with Surine™ to generate a 
750ng/mL EtG solution.  The dilution was performed using the dilution formula, 
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C1V1 = C2V2.  Using the formula, the desired volume of original solution was 
calculated as shown below. 
(0.001g/mL EtG) (V1) = (7.5x10
-7g/mL EtG)(28mL) 
V1 = 0.021mL = 21µL 1mg/mL EtG solution 
The diluted solution was created using Surine™ (27.979mL) and the 1mg/mL 
EtG solution (0.021mL).  In total, each testing cycle used 28mL of 750ng/mL EtG 
solution.  A majority of the solution volume (20mL) was adulterated with a particular 
zinc product.  The remaining solution volume (8mL) was used as a positive control.  
Surine™ (8mL) was used as the negative control in each series.   
Each zinc source was massed to produce a 15mg/mL concentration of zinc 
when added to the 750ng/mL EtG solution (20mL).  Table E in Appendix A indicates 
the masses of zinc added to each EtG solution.  All zinc solutions were vortexed for 
one minute to promote dissolution of the salt.  Tablets from Nature’s Bounty and 
Nature Made were ground into powders using a mortar and pestle before their 
addition to the positive EtG solution.   
  One milliliter aliquots of all five solutions, the positive control, the three 
trial samples, and the negative control were pipetted into labeled microcentrifuge 
tubes.  Five cards of a selected immunoassay brand were opened and labeled with the 
aforementioned numbering scheme.  Each card was inserted into the solution for at 
least thirty seconds or until the testing region had been completely saturated with 
solution.  Each test was analyzed five minutes after the test strip became saturated.  
Results were identified as positive (+), negative (-), or invalid (I) for each test.  This 
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process was repeated for each immunoassay brand and resulted in twenty-five trials.  
The entire process was repeated for each zinc source and resulted in a total of 125 
trials. 
 
2.3.2 Human Urine Method 
 Four different human urine donor samples were tested using SmarTox test kits in 
order to determine their viability as a matrix lacking any initial concentration of EtG.  
All donors tested positive for the presence of EtG in their urine despite differences in 
age and reported alcohol abstinence.  All donors were then screened using the 
remaining four testing kits to determine which donor’s urine indicated the absence of 
EtG on the greatest number of brands.  A young male donor was chosen based on a 
reported complete abstinence of alcohol since birth and the sample’s negative results on 
two of the five immunoassay kits.  Previous steps in the Surine™ method were 
employed to create a 750ng/mL EtG solution and all zinc-adulterated solutions.  Due to 
immunoassay supply constraints, only four tests were conducted for each zinc source 
resulting in twenty trials with each testing kit and forty trials total. 
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3. RESULTS 
3.1 Experimental Results Using Surine™ 
 Using PreScreen Plus test kits, Sigma-Aldrich ZnSO4•7H2O solutions produced 
consistent negative results for the presence of EtG.  Solutions of Sigma-Aldrich 
ZnSO4•1H2O, Nature’s Bounty zinc gluconate, and NatureMade zinc gluconate 
produced consistent positive results for the presence of EtG.  Designs for Health’s Zinc 
Challenge generated one positive result and two invalid results (Appendix A, Table F).  
Using the ETG Dip Card Test kit, negative results were observed when the test 
strips were exposed to NatureMade zinc gluconate.  Invalid results were produced when 
the test strips were exposed to Sigma-Aldrich ZnSO4•7H2O, Sigma-Aldrich 
ZnSO4•1H2O, and Designs for Health ZnSO4•1H2O.  Positive results were yielded 
when the test strips were exposed to Nature’s Bounty zinc gluconate (Appendix A, 
Table F). 
Using the One Step EtG Urine Test Panel kit, negative results were observed 
when the test strips were exposed to Nature’s Bounty zinc gluconate and NatureMade 
zinc gluconate.  Invalid results were produced when the test strips were exposed to 
solutions containing Sigma-Aldrich ZnSO4•7H2O, Sigma-Aldrich ZnSO4•1H2O, and 
Designs for Health ZnSO4•1H2O.  No positive results were yielded using this 
immunoassay (Appendix A, Table F).  
Using the EtG Alco-Screen kit, a single negative result was observed when the 
test strips were exposed to NatureMade zinc gluconate.  Invalid results were produced 
when the test strips were exposed to Sigma-Aldrich ZnSO4•7H2O, Sigma-Aldrich 
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ZnSO4•1H2O, and Designs for Health ZnSO4•1H2O.  Positive results were yielded 
when the test strips were exposed to Nature’s Bounty zinc gluconate and NatureMade 
zinc gluconate (in two of three trials; Appendix A, Table F).  Figure 11 shows a set of 
trials including a positive control, three experimental trials, and a negative control. 
     
Figure 11. Experimental Set of 1.4.1 Trials 
Using the SmarTox test kit, no negative results were observed when the test 
strips were exposed to any zinc solutions.  Invalid results were produced when the test 
strips were exposed to Sigma-Aldrich ZnSO4•7H2O, Sigma-Aldrich ZnSO4•1H2O, and 
Designs for Health ZnSO4•1H2O.  Positive results were yielded when the test strips 
were exposed to Nature’s Bounty zinc gluconate and NatureMade zinc gluconate 
(Appendix A, Table F). 
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Appendix A, Table G depicts the percent of positive, invalid, and negative trials 
based on five different zinc sources.  Sigma-Aldrich ZnSO4•7H2O produced zero 
positive readings (0%), twelve invalid readings (80%), and three negative readings 
(20%).  Sigma-Aldrich ZnSO4•1H2O produced three positive readings (20%), twelve 
invalid readings (80%), and zero negative readings (0%).  Nature’s Bounty zinc 
gluconate produced twelve positive readings (80%), zero invalid readings (0%), and 
three negative readings (20%).  NatureMade zinc gluconate produced eight positive 
readings (53%), zero invalid readings (0%), and seven negative readings (47%).  
Designs for Health ZnSO4•1H2O produced one positive readings (7%), fourteen invalid 
readings (93%), and zero negative readings (0%). 
Appendix A, Table H depicts the percent of positive, invalid, and negative trials 
based on five different immunoassay brands.  PreScreenPlus cards produced ten 
positive results (67%), two invalid trials (13%), and three negative trials (20%).  ETG 
Dip Card Test cards produced three positive results (20%), nine invalid trials (60%), 
and three negative trials (20%).  One Step EtG Urine Test Panel cards produced zero 
positive results (0%), nine invalid trials (60%), and six negative trials (40%). ETG 
Alco-Screen cards produced five positive results (33%), nine invalid trials (60%), and 
one negative trial (7%).  Finally, SmarTox cards produced six positive results (40%), 
nine invalid results (60%), and zero negative results (0%).   
 
3.2 Preliminary Human Urine Screening 
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 Appendix A, Table I represents the test results for the detection of EtG in donated 
samples of human urine.  All samples were tested within 48 hours of donation.  The 
SmartTox testing kit was used to identify EtG because there was a surplus of this 
testing kit available for use.  The results indicated that UTAK human urine produced a 
faint negative result, which was deemed unsuitable for further testing.  The faintness of 
the testing and control region bands were subject to lightening due to zinc adulteration 
as observed using Surine™.  Sample R08-00162 was determined to be positive for EtG, 
yet the donor reported zero alcohol consumption for one week prior to donation.  
Samples were collected from two donors who had abstained from alcohol since birth; 
TT84600, CJ88540, CJ89700A, and CJ89700B.  All preliminary screenings indicated 
positive results.  Finally, an expected positive control taken from a donor, DL810900, 
was collected less than two days following alcohol consumption.  Sample DL810900 
indicated an absence of EtG. Lastly, a previously mentioned sample, CJ88540, was 
chosen for testing using all five immunochromatographic assays as the most likely 
candidate for further zinc adulteration trials.  Two screening kits, PreScreen Plus and 
One Step EtG Urine Test Panel, indicated no presence of EtG.  All other testing kits 
produced positive results and no further testing was conducted using them. 
 
3.3 Experimental Results Using Human Urine 
Appendix A, Table J represents the test results for the detection of EtG in a 
variety of zinc-adulterated human urine solutions using the PreScreen Plus kit.  Positive 
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results were yielded when the test strips were exposed to all zinc sources.  Table K 
indicates that all PreScreen Plus tests detected the presence of EtG. 
Appendix A, Table J represents the test results for the detection of EtG in a 
variety of zinc-adulterated human urine solutions using the One Step EtG Urine Test 
Panel kit.  Negative results were observed when the test strips were exposed to all zinc 
sources.  Table L indicates that all tests performed on One Step EtG Urine Test Panel 
kits produced false negative readings. 
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4. DISCUSSION 
4.1 Effectiveness of Different Immunoassay Screening Tests 
 A variety of immunoassay screening kits were evaluated from five separate 
sources and manufacturers.  Package inserts from each of these kits described numerous 
disclaimers and limitations to the effectiveness of the test itself.  Each immunoassay 
screening test seemed reliable as an effective measure to detect, even qualitatively, the 
presence of EtG in synthetic urine.  Eighty percent of PreScreen Plus and ETG Dip 
Card Test trials indicated a positive or invalid result.  One Step EtG Urine Test Panels 
proved effective in 60% of all trials.  EtG Alco-Screen and SmarTox test kits were 
unaffected by zinc in greater than 90% of their respective trials.  Overall, 83% of all 
Surine™ trials produced a positive or invalid result.  This is a promising result in 
support of the use of these immunochromatographic assays.  In a greater context this 
result only proves that zinc is unable to adulterate most tests within a clean and lab-
grade matrix.   
 In comparison, human urine trials using these immunoassay brands indicated that 
most produced false positives for urine derived from an abstinent donor and false 
negative for urine derived from a donor who had consumed alcohol within three days of 
donation.  PreScreen Plus tests indicated the presence of EtG regardless of the zinc 
source used to adulterate the solution.  The One Step EtG Drug Test Panel kits 
produced false negative in all zinc-adulterated trials.  All other immunoassays produced 
false positives during preliminary testing of human urine samples.  The PreScreen Plus 
insert stated that interfering substances, adulterants, certain foods, and food 
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supplements could produce false positives or negatives, although specific gravity, pH, 
and cross-reactivity studies found no measurable effect on the accuracy of the test(39).  
In particular, these indicated no effect from a list of 92 organic compounds ranging 
from expected biological components such as cholesterol and hemoglobin to common 
consumer compounds such as caffeine and salicylic acid (Table M).  No inorganic 
compounds were tested such as the zinc complexes examined in this study.   
 
4.2 The Effectiveness of Different Zinc Sources 
 Sigma-Aldrich zinc sulfate heptahydrate and zinc sulfate monohydrate produced 
false negative or invalid results while Designs for Health zinc sulfate monohydrate 
produced positive or invalid results.  Overall, 38 of the 75 Surine™ trials conducted 
produced an invalid result at a concentration (15mg/mL) much greater than reported 
post-ingestion zinc concentrations(2, 3).  An experienced and observant forensic 
scientist or laboratory technician could recognize this invalid result and request a 
second sample from the donor.  Moreover, 23 of the 75 Surine™ trials indicated the 
presence of EtG regardless of zinc adulteration.  Zinc, even when directly added to a 
test sample, seems to be a poor adulterant when intended to produce a false negative in 
drug of abuse testing.  At optimal conditions, 81% of tests produced positive or invalid 
results while only 19% produce a false negative result.   
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4.3 Zinc Salts and Invalid Test Results 
 Zinc had a profound effect on the validity of various immunochromatographic 
assays.  A majority of tests were invalidated when a form of zinc sulfate was present.  
During positive control and negative control trials the pink color of the enzyme-labeled 
dye was visible and moved up the test strip as it became saturated resulting in two 
visible bands in the C and T regions.  In contrast, the addition of zinc sulfate caused no 
visible pink dye as both the control and test regions became saturated with solution.  A 
clear difference is visible in the presence of pink dye between the controls and the 
experimental trials of Surine™ set of 1.5.2.  
     
Figure 12. Experimental Set of 1.5.2 Trials 
(From left to right: Positive Control, Trial A, Trial B, Trial C, Negative Control) 
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Further research indicates that zinc ions can adhere to protein binding sites and can 
cause conformational changes in proteins(40, 41).  In particular, zinc ions have been 
reported to bind to amino acids that can be ionized such as aspartate (Figure 11). 
 
Figure 13. Zinc ion bonding to aspartate molecules 
(Produced using ChemBioDraw Ultra 14.0) 
 
 No immunoassay brands specified the exact antibody proteins present upon the 
test strip.  Each antibody was labeled as a goat or mouse antibody.  No other 
description was provided.  Considering that many proteins are chains of several 
hundred amino acids, it is likely that an ionized amino acid would be present within 
either the goat antibody, the mouse antibody, or both.  Out of the thirty common amino 
acids within the human body, two have a negatively charged sidechain, aspartic acid 
and glutamic acid, that could readily bond with a zinc ion.  If these amino acids are 
present in the binding site of the antibody or if they have caused a conformational 
change in the antibody, then they could inhibit the attachment of EtG or the enzyme-
labeled dye.  This could account for the lack of color when the test strip was saturated 
with a zinc solution.  However, zinc gluconate did not have the same effect on 
immunoassay tests. 
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 A well-established concept in inorganic chemistry is that a polydentate ligand 
(Figure 13), a molecule that binds to a metal using more than one atom, has a stronger 
bond to the metal than a monodentate ligand (Figure 12).  Zinc sulfate consists of a 
single zinc cation bound to two of the oxygens within the sulfate anion (Figure 9).  In 
contrast, zinc gluconate consists of two gluconate anions bound by two oxygen atoms 
each to the zinc cation (Figure 10).  Considering that all zinc sources were dissolved in 
water, zinc sulfate may more easily dissociate and, therefore, more zinc ions would be 
available for binding to the various antibodies on the test strip. 
 
 
Figure 14. Four monodentate ligands binding to a zinc ion 
(Produced using ChemBioDraw Ultra 14.0) 
 
 
Figure 15. Two bidentate ligands binding to a zinc ion 
(Produced using ChemBioDraw Ultra 14.0) 
 
4.4 Human Urine as a Matrix 
 When human urine was screened, a number of preliminary results were 
inconsistent and irregular based on each donor source.  Utak urine produced faintly 
negative test bands during preliminary testing that differed greatly from the high 
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intensity bands observed in the Surine™ negative controls.  When the company was 
contacted to determine if it purifies its urine to remove EtG, it was stated that the 
company had not tested the urine for the presence of EtG and did not do so as part of 
their standard operating protocols.  Moreover, collected specimens from abstaining and 
abstinent donors that were expected to produce negative results, instead, generated 
positive results even when donors were verified to have had no contact with alcoholic 
beverages.  Although these results are not entirely unexpected, they prove problematic 
for subsequent zinc adulterated testing.  Numerous studies have shown that alcohol is 
ubiquitous in countless foods, non-alcoholic beverages, and commercial products(24, 
25).  It is likely that the two completely abstinent donors had come into contact with 
ethanol through a different source.  Other studies state that inhalation and skin contact 
are effective methods of ethanol introduction into the body(30-32).  Nevertheless, this 
possibility leaves a limited number of assay kits to use when testing for zinc 
adulteration.  Unfortunately, human urine is the basis for effective preliminary testing, 
and so, the immunochromatographic assays employed in this testing may not be the 
most appropriate when analyzing human urine.      
 
4.5 Alternative Biomarkers and Matrices 
Considering the difficulty with which urine was observed to produce rapid and 
reliable results when testing for the presence of EtG, other matrices and biomarkers are 
recommended.  Several papers have been published in recent months discussing this 
recommendation(5, 42, 43).  Kummer and colleagues have evaluated and collected 
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literature on various sample types by which to determine alcohol consumption in living 
humans.  They examined literature on such samples as dried blood spots, dried urine 
spots, sweat, saliva, exhaled breath, hair, nail, meconium, umbilical cord and 
placenta(5).  Their conclusions indicate that EtG and EtS are still the most widely 
analyzed compounds, but that FAEEs, PEth compounds, and carbohydrate-deficient 
transferrin (CDT) have potential benefits as corroborating markers.  Also, the review 
suggests that hair may be the best suited matrix to monitor alcohol consumption.  
 
Table D.  2016 Kummer et al. Literature Review Summary of Findings(5) 
 Ethanol CDT EtG and EtS PEth FAEEs 
Dried blood 
spots (DBS) 
Not discussed Stable for 2 
weeks when 
refrigerated or 
frozen 
Window of 
detection 
limited to ~10 
hours 
>16 days to 
detect after 
repeated high 
alcohol 
consumption 
Not discussed 
Dried urine 
spots (DUS) 
Not discussed Not discussed - Not subject to 
bacterial 
degradation 
- Stable for ≤ 7 
days 
Not discussed Not discussed 
Sweat 
SCRAM II can 
detect drinking 
if person has 
more than one 
drink 
Not discussed Detectable at 
100x lower 
concentration 
than in blood 
Not discussed 8-12 days to 
reach highest 
concentration 
Saliva 
- Similar profile 
of detection as 
blood and 
breath 
- Unabsorbed 
alcohol can bias 
results 
Not discussed - Detected up to 
11.5hrs post 
alcohol 
consumption 
- Limited 
quantitation 
studies 
Not discussed Not discussed 
Exhaled 
breath 
Not discussed Not discussed Not discussed - No significant 
correlation 
between PEth 
and BAC 
Not discussed 
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- Contains non-
modified 
phospholipid 
control 
Hair 
Not discussed Not discussed Can detect long 
term and/or 
repeated 
alcohol 
consumption 
- Detection 
affected by hair 
treatments 
(bleaching, 
dyeing, 
straightening)  
Not discussed - Unexplained 
baseline in 
teetotalers 
- False 
positives due to 
frequently used 
hair products 
Nail 
Not discussed Not discussed - Detectable 
difference 
between 
abstainers, 
regular 
consumers, and 
abusers 
- No current 
stability studies 
Not discussed Not discussed 
Meconium 
Not discussed Not discussed - Suggested 
cutoff values 
1.5-2nmol/g 
EtG and 
0.0012nmol/g 
EtS 
- Cutoff values 
vary between 
researchers 
Not discussed - Cumulative 
FAEEs cutoff 
values more 
efficient 
- Can detect 
binge drinking 
by mother 
Umbilical 
cord and 
placenta 
Not discussed Not discussed - Limited 
studies 
conducted 
- Quantifiable 
to detect in 
utero EtOH 
exposure 
- Limited 
studies 
conducted 
Not discussed 
 
 A further study into promising biomarkers was conducted by Luginbühl and his 
colleagues and included N-acetyltaurine (NAcT), a product of acetate, taurine, and 
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acetyl-CoA(43).  Eight volunteers between the ages of 19 and 26 were asked to abstain 
from alcohol for two weeks.  Each volunteer then consumed one dose (125-210mL) of 
alcohol based on body mass.  Blood and urine samples were taken before alcohol 
consumption.  Four more blood and urine samples were collected within five hours of 
consumption and again at 24-hour intervals for the next four days.  All specimens were 
analyzed by HPLC-MS and a detection window of 24 hours was determined(43).  
Nevertheless, future studies concerning NAcT produced without alcohol consumption, 
such as following endurance running, has not been investigated further. 
A recent paper by Salomone et al. compares various sample preparation methods for 
detecting EtG in hair(44).  The study examines the two different methods, cutting or 
milling, by which hair samples are processed for testing this metabolite.  Fifteen donors 
contributed approximately 2g of hair each.  The samples were homogenized and then cut 
or milled.  Each method was evaluated over the course of ten trials.  Further research was 
conducted concerning a pool of 781 chest or head hair samples from alcohol abusers in 
2015.  Similar to the first testing method, samples were collected and then divided into 
two separate aliquots for cutting and milling, respectively.  Researchers found that cutting 
and milling procedures generated reproducible results.  On the other hand, comparison 
testing on the 781 samples yielded a preferred method.  Only 205 collected specimens 
produced measurable amounts of EtG, but a majority of cases (172 of the 205) were 
shown to produce higher concentrations of EtG using the milling method.   
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5. CONCLUSIONS 
 In conclusion, a variety of zinc sources and immunoassay test kits revealed that, 
at best, most immunoassay cards can be invalidated, but few yield false negatives when 
exposed to zinc compounds.  Both analytical and commercial forms of hydrated zinc 
sulfate tended to invalidate immunoassay screening tests.  Four of the five 
immunoassay brands were invalidated excluding PreScreen Plus.  On the other hand, 
exposure to zinc gluconate solutions yielded either clear positive results or false 
negative results.  Prescreen Plus, ETG Alco-Screen, and SmarTox kits were unaffected 
by zinc gluconate.  ETG Dip Card Test and One Step EtG Urine Test Panel kits 
indicated false negatives when exposed to NatureMade zinc gluconate and Nature’s 
Bounty zinc gluconate for the latter.  No definitive cause for this immunoassay 
behavior has been verified, however, zinc ions, particularly those released from zinc 
sulfate may be affecting the immunochemical dyes that bind at the control and test 
regions.  Invalidated tests showed no dye movement up the immunoassay card while 
becoming saturated with zinc sulfate solution. 
 Moreover, these immunoassay kits were found to be unsuitable for reliable 
qualitative and quantitative detection of EtG.  Incidental exposure to ethanol through a 
variety of other sources puts this methodology at risk of expending time verifying false 
positives in an already backlogged analytical field.  Higher cut-off values closer to 
1000ng/mL EtG would lessen the number of false positives, but they have the potential 
to exclude people who have intentionally consumed alcohol in lower volumes.  Instead, 
it is recommended that alternative biomarkers and sampling strategies be used when 
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determining alcohol consumption.  Ethyl sulfate has been shown to yield less false 
positive and negative results.  Furthermore, hair sampling has been proven to provide a 
more effective method by which to examine EtG if it continues to be relied upon as the 
metabolite of interest for the detection. 
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6. FUTURE CONSIDERATIONS 
 This research provokes a multitude of questions concerning what may be causing 
invalidation of the immunoassay test kits.  Previous research has indicated that zinc 
sulfate has the potential to interfere with and alter the results of analytical immunoassay 
testing methods such as EMIT and ELISA(2, 3).  Although, further research is 
necessary to understand the mechanism by which zinc interferes with the 
immunochemical reaction and invalidates the analytical method.  In addition, zinc 
gluconate showed potential to produce false negatives when used in conjunction with 
certain immunoassay brands.  Future tests could be conducted to determine the limits at 
which zinc gluconate can adulterate a urine sample containing drugs of abuse.  Also, 
zinc gluconate has not yet been reported to do this and the mechanism by which it 
interferes with immunoassays is unclear.  Finally, there was significant difficulty in the 
ability for this study to find a human donor whose urine did not indicate the presence of 
EtG regardless of age or abstinence from alcohol.  Studies have been conducted on 
high-content EtOH mouthwash and hand sanitizers, but numerous other household 
products contain EtOH as well(31, 32).  Future research to determine the level of 
incidental exposure to alcohol could determine whether immunochromatographic 
assays are sensitive enough to differentiate between intentional alcohol consumption 
and unintentional contact. 
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APPENDIX A 
 
Table E. Zinc Product Masses Used to Produce 15mg/mL Adulterated EtG 
Solutions 
Zinc Source 
Zinc Product 
Mass 
750ng/mL EtG 
Solution Volume 
Zinc 
Concentration 
Zinc Sulfate 
Heptahydrate 
 305.5mg 20mL 15mg/mL 
Zinc Sulfate 
Monohydrate 
301.0mg 20mL 15mg/mL 
Nature’s Bounty 
Zinc Gluconate 
6 tablets (3.8227g) 
(50mg Zn/tablet) 
20mL 15mg/mL 
Nature Made Zinc 
Gluconate 
10 tablets 
(2.9131g) (30mg 
Zn/tablet)) 
20mL 15mg/mL 
DFH Zinc Sulfate 
Monohydrate 
239.9mg 16mL 15mg/mL 
 
Table F. Test Results of Immunoassay Dip Cards for the Presence of EtG in Zinc-
Adulterated Surine Solution 
P = positive control 
1 & 2 = trial numbers 
N = negative control 
Immunoassay 
PreScreen 
Plus 
ETG Dip 
Card Test 
One Step 
EtG Urine 
Test Panel 
ETG Alco-
Screen 
SmartTox 
Zinc Source P 1 2 3 N P 1 2 3 N P 1 2 3 N P 1 2 3 N P 1 2 3 N 
Zinc Sulfate 
Heptahydrate 
+ - - - - + I I I - + I I I - + I I I - + I I I - 
Zinc Sulfate 
Monohydrate 
+ + + + - + I I I - + I I I - + I I I - + I I I - 
Nature’s 
Bounty Zinc 
Gluconate 
+ + + + - + + + + - + - - - - + + + + - + + + + - 
Nature Made 
Zinc 
Gluconate 
+ + + + - + - - - - + - - - - + - + + - + + + + - 
DFH Zinc 
Sulfate 
Monohydrate 
+ + I I - + I I I - + I I I - + I I I - + I I I - 
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Table G. Percentage of Positive, Invalid, and Negative Test Results Based on Zinc 
Source in Surine™ 
Zinc Source 
Positive 
Trials 
Percent 
Positive 
Invalid 
Trials 
Percent 
Invalid 
Negative 
Trials 
Percent 
Negative 
Zinc Sulfate 
Heptahydrate 
0 0% 12 80% 3 20% 
Zinc Sulfate 
Monohydrate 
3 20% 12 80% 0 0% 
Nature’s Bounty 
Zinc Gluconate 
12 80% 0 0% 3 20% 
Nature Made Zinc 
Gluconate 
8 53% 0 0% 7 47% 
DFH Zinc Sulfate 
Monohydrate 
1 7% 14 93% 0 0% 
Average 4.8 32% 7.6 51% 2.6 17% 
 
Table H. Percentage of Positive, Invalid, and Negative Test Results Based on 
Immunoassay Brand Exposed to Zinc-Adulterated Surine™ Solutions 
Immunoassay Test 
Positive 
Trials 
Percent 
Positive 
Invalid 
Trials 
Percent 
Invalid 
Negative 
Trials 
Percent 
Negative 
PreScreen Plus 10 67% 2 13% 3 20% 
ETG Dip Card Test 3 20% 9 60% 3 20% 
One Step EtG Urine 
Test Panel 
0 0% 9 60% 6 40% 
ETG Alco-Screen 5 33% 9 60% 1 7% 
SmarTox 6 40% 9 60% 0 0% 
Average 4.8 32% 7.6 51% 2.6 17% 
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Table I. Preliminary Human Urine Testing for the Presence of EtG 
 
R08-00162 – Sample collected after one week of alcohol abstinence 
 
TT 84600, CJ 88540, CJ 89700A, CJ 89700B – Samples were collected from two 
donors, TT and CJ 
 
DL810900 – Sample collected within 48hrs of alcohol consumption 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Donor 
PreScreen 
Plus 
ETG Dip 
Card Test 
One Step 
EtG Urine 
Test Panel 
ETG Alco-
Screen 
SmartTox 
UTAK             _ _ _ 
R08-
00162 
            + + + 
TT 
84600 
            + + + 
CJ 88540 - - - + + + - - - + + + + + + 
CJ 
89700A 
            + + + 
CJ 
89700B 
            + + + 
DL 810900             - - - 
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Table J. Test Results of Immunoassay Dip Cards for the Presence of EtG in Zinc-
Adulterated Human Urine Solution 
P = positive control 
1 & 2 = trial numbers 
N = negative control 
 
Table K. Percentage of Positive, Invalid, and Negative Test Results Based on Zinc 
Source in Human Urine 
Zinc Source 
Positive 
Trials 
Percent 
Positive 
Invalid 
Trials 
Percent 
Invalid 
Negative 
Trials 
Percent 
Negative 
Zinc Sulfate 
Heptahydrate 
2 50% 0 0% 2 50% 
Zinc Sulfate 
Monohydrate 
2 50% 0 0% 2 50% 
Nature’s Bounty Zinc 
Gluconate 
2 50% 0 0% 2 50% 
Nature Made Zinc 
Gluconate 
2 50% 0 0% 2 50% 
DFH Zinc Sulfate 
Monohydrate 
2 50% 0 0% 2 50% 
 
Table L. Percentage of Positive, Invalid, and Negative Test Results Based on 
Immunoassay Brand Exposed to Zinc-Adulterated Human Urine Solutions 
Immunoassay Test 
Positive 
Trials 
Percent 
Positive 
Invalid 
Trials 
Percent 
Invalid 
Negative 
Trials 
Percent 
Negative 
PreScreen Plus 10 100% 0 0% 0 0% 
One Step EtG Urine 
Test Panel 
0 0% 0 0% 10 100% 
 Immunoassay PreScreen Plus One Step EtG Urine Test Panel 
 Zinc Source P 1 2 N P 1 2 N 
Zinc Sulfate Heptahydrate + + + - + - - - 
Zinc Sulfate Monohydrate + + + - + - - - 
Nature’s Bounty Zinc 
Gluconate 
+ + + - + - - - 
Nature Made Zinc Gluconate + + + - + - - - 
DFH Zinc Sulfate 
Monohydrate 
+ + + - + - - - 
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Table M. Non Cross-Reactive Substances with One Step PreScreen Plus Dip Cards 
Compounds A - C Compounds C - I Compounds I - P Compounds P – Z 
[100µg/mL] [100µg/mL] [100µg/mL] [100µg/mL] 
Acetophenetidin L – Conitine Isoxsuprine D-Pseudoephedrine 
N-
Acetylprocainamide 
Cortisone Ketoprofen Quinidine 
Acetylsalicylic Acid Creatinine Labetalol Quinine 
Aminopyrine Deoxycorticosterone Loperamide Salicylic Acid 
Amoxicillin Dextromethorphan Meprobamate Serotonin 
Ampicillin Diclofenac Methoxyphenamine Sulfamethazine 
L-Ascorbic acid Difunisal Methylphenidate Sulindac 
Apomorphine Digoxin Nalidixic acid Tetracycline 
Aspartame Diphenhydramine Naproxen 
3- Acetate 
Tetrahydrocortisone 
Atropine 
Ethyl-p-
aminobenzoate 
Niacinamide Tetrahydrocortisone 
Benzilic Acid β-Estradiol Nifedipine Tetrahydrozoline 
Benzoic Acid Estrone-3-sulfate Norethindrone Thiamine 
Bilirubin Erythromycin Noscapine Thioridazine 
D,L-
Brompheniramine 
Fenoprofen D,L-Octopamine D,L-Tyrosine 
Caffeine Furosemide Oxaic acid Tolbutamide 
Cannabidiol Gentisic acid Oxolinic acid Triamterene 
Chloralhydrate Hemoglobin Oxymetazoline Trifluoperazine 
Chloramphenicol Hydralazine Papaverine Trimethoprim 
Chlorothiazide Hydrochlorothiazide Penicillin-G D,L-Tryptophan 
D,L – 
Chlorpheniramine 
Hydrocortisone Perphenazine Uric Acid 
Chlorpromazine 
o-Hydroxyhippuric 
acid 
Phenelzine Verapamil 
Cholesterol 3-Hydroxytyramine Prednisone Zomepriac 
Clonidine D,L-Isoprototerenol D,L-Propanolol  
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Agents Actions Agents and Actions 
Alcohol Alcohol Alcohol and Alcoholism 
Alcohol Research Alcohol Research and Health 
Am J Clin Pathol American Journal of Clinical Pathology 
Am J Infect Control American Journal of Infection Control 
Anal Bioanal Chem Analytical and Bioanalytical Chemistry 
Anal Methods Analytical Methods 
Ann Clin Biochem Annals of Clinical Biochemistry 
Arch Exp Pathol Pharmikol Archiv for Experimentelle und Pathologie Pharmakologie 
Clin Chim Acta Clinca Chimica Acta 
Drug Test Anal Drug Testing and Analysis 
Eur J Pharmacol European Journal of Pharmacology 
Forensic Sci Int Forensic Science International 
Int J Legal Med International Journal of Legal Medicine 
J Anal Toxicol Journal of Analytical Toxicology 
J Chromatogr Sci Journal of Chromatographic Science 
J Forensic Sci Journal of Forensic Sciences 
J Nutr Journal of Nutrition 
Pharmac Ther Pharmacology & Therapeutics 
Proc Natl Acad Sci Proceedings of the National Academy of Sciences 
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